Partial prevention of glucocorticoid-induced osteocyte deterioration with osteocrin gene therapy
C. M. Mazur, C. D. Castro Andrade, T. Sato, M. Bruce, M. L. Bouxsein, J. S. Wang, M. N. Wein
This study tests osteocrin gene therapy to prevent glucocorticoid-induced osteocyte damage in mice, finding partial protection against osteocyte death but not all skeletal effects.
bioRxiv · Nov 19, 2021 · PreprintPhysiology